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Supplementary Information (SI) 
SI Results and Discussion 
Structural Determination and Analysis of the hCLDN-4/cCpE Complex. hCLDN-4 was 
recombinantly expressed and isolated as detailed in SI Methods. The structure of the hCLDN-
4/cCpE complex was determined to 3.37 Å from a single crystal dataset in space group P212121, 
with cell dimensions of 70.4, 116.2, and 118.1 Å. Phases for the complex were determined with 
molecular replacement (MR) by independent placement of each protein using a poly-alanine model 
of hCLDN-9 and the cCpE from PDB ID 6ov2 (1). Post-MR maps allowed modelling of 87% of full-
length hCLDN-4 and 100% of cCpE with no structural breaks in non-terminal regions. The 
asymmetric unit contains a single hCLDN-4/cCpE complex, like our previous structures of hCLDN-
9 bound to cCpE (1). This single complex within the crystal differs from other claudin/cCpE complex 
structures, which crystallize in non-physiological antiparallel multimeric arrays that influence 
intermolecular interactions and structural analysis (Figure S5) (2-4). Data collection and refinement 
statistics are summarized in Table S1. 
Structural analysis of the hCLDN-4/cCpE complex reveals a plethora of intermolecular 
interactions occur between proteins. In ECS2, polar interactions (distances 2.4-4.0 Å) between five 
residues make eleven hydrogen bonds with cCpE, six which are mediated by main chain atoms 
(Figure S6A). Additionally, hCLDN-4 Asp146 and cCpE Arg227, and Arg158 of hCLDN-4 and 
Asp225 of cCpE form two ionic interactions and help bond the two molecules together. Non-polar 
interactions (distances 3.0-4.0 Å and PDBePISA buried surface areas >50 Å2 (5)) within ECS2 are 
focused on Leu151 and Ala153, part of the NPLVA153 motif. In ECS1, eight residues throughout the 
segment form polar interactions with cCpE exclusively through nine hydrogen bonds, one coming 
from a main chain carbonyl (Figure S6B and S6C). No ionic interactions exist in ECS1 and only 
Phe35 makes significant non-polar contacts. Generally, contacts between hCLDN-4 and cCpE are 
sparsely spread across β1-β4, ECL1, and TM2 in ECS1, while in ECS2 they are concentrated on 
ECH2 and ECL4.  
Contradictory findings using various biochemical and cellular techniques have contended that 
one of two regions within ECS2 is solely responsible for driving cCpE binding to claudins. 
Previously, the NP(V/L)(V/L)(P/A153) motif (6-8) or an ECS2 basic region that electrostatically 
interacts with an acidic cleft of cCpE (9) have been shown to be essential for complex association 
and cytotoxicity. The structure of the hCLDN-4/cCpE complex demonstrates nine residues in ECS1 
and eight residues in ECS2 are involved in binding cCpE (Figure S7). Interactions between 
hCLDN-4 and cCpE are concentrated on ECS2 while they are sparsely spread across ECS1. Of 
the 69 total residues that constitute the two ECS, 48 (70%) reside in ECS1 and 21 (30%) reside in 
ECS2. Analysis of the intermolecular contacts between hCLDN-4 and cCpE reveals 38% of all 
ECS2 residues compared to only 18% of all ECS1 side chains interact with cCpE (Figure S7A). 
Despite having 2.3-fold fewer amino acids, ECS2 uses a greater percentage of residues to interact 
with cCpE compared to ECS1, creating a focused cCpE binding region. This focused group of 
interactions on the smaller ECS2 domain explain why NP(V/L)(V/L)(P/A153) motif mutations alter 
cCpE binding. 
In this report we explain through structure/function analyses how both classes of interactions 
facilitate hCLDN-4/cCpE complex formation and preservation. Leu151 in the NPLVA153 motif 
functions to slow cCpE dissociation (Table 1) by accessing a surface pocket on cCpE and forming 
non-polar side chain and polar backbone interactions (Figures S6 and S11), while ECS2 
electrostatics outside of ECL4 facilitate complex association via a hydrogen bond network that 
comprises the cCpE-binding motif (Figure 3). These findings allow us to speculate that both modes 
of interactions play specific roles in toxin binding—electrostatics drive association and the 
NPLVA153 motif prevents dissociation. This idea would explain how in the absence of one mode—
an NPLVA153 motif in hCLDN-1 (DPMTP154) and hCLDN-19 (NPSTP154)—that these subtypes can 
still bind toxin and render cells susceptible to CpE cytotoxicity (Figure 4I and (1)). In combination 
with our finding that residues that interact with cCpE are extensively spread across the hCLDN-4 





cannot distinguish CpE receptors. In summary, our analyses reveal that both the NPLVA153 motif 
and electrostatic interactions outside of it play supportive roles in ECS2 binding to cCpE, that these 
two binding modes direct distinct binding processes, that both ECS support cCpE binding, and that 
ECS2 residues alone cannot be used to distinguish CpE receptors from non-receptors. Our results 
unite two former disparate ideas that appeared conflicting, and resolve a more nuanced amino 
acid-level understanding of CpE targeting of claudins.  
CpE Disruption of Claudin Cis/Trans Assemblies and Paracellular Pores. Between β1 and β2 
of cCpE a ten residue ⍺-helix forms from Asn210-Pro219 (Figures 2B and S6B) The Pro219 of 
cCpE comes within 3.2 Å of hCLDN-4 and interacts with Cys64 and Lys65, residues that form the 
Cys54–64 disulfide bridge and impart anion selectivity to hCLDN-4 (10). These interactions allow 
cCpE to affect the conformation of the hCLDN-4 β3 to β4 “little finger” that is tethered by the Cys54–
64 disulfide bridge. Targeting of this hCLDN-4 region by cCpE is interesting because: i) the Cys54–
64 disulfide is conserved in all claudins, making this interaction a potential claudin fold recognition 
site; and ii) Lys65 is the anion-selective residue in CLDN-4 and equivalent residue 65 side chains 
in other claudins impart ion-selectivity (10, 11). Pro219 and this helix in cCpE could therefore 
disrupt claudin paracellular pore formation through interactions in this region. Moreover, Pro219 
comes within 3.8 Å of Gln63. This is notable because the equivalent residue in mCLDN-15, Asn61, 
has been shown to reside at the interface between cis interacting claudin homodimers (12). These 
observations lead us to conclude that Pro219 and the helix of cCpE could be used for claudin fold 
recognition in order to disable claudin cis and/or trans assemblies, resulting in losses to ion 
selectivity via paracellular pore disruption. The cCpE’s targeting of hCLDN-4 regions used for these 
specific functions is worth further investigation in other subtypes. 
Structural Comparisons of Claudins Bound to cCpE. To date, nine crystal structures of claudins 
have been determined, eight of which are in complex with cCpE (1-4, 13). The cCpE bound to 
hCLDN-4 exhibits no major conformational alterations compared to other structures and has root-
mean-square deviations (RMSD) between Cα atoms that range between 0.4–0.7 Å (Figure S8A). 
Compared to other structures, the cCpE bound to hCLDN-4 is most similar to cCpE from the 
complex with hCLDN-9>full-length CpE>cCpE from the complex with mCLDN-19>cCpE from the 
complex with mCLDN-3>cCpE from the complex with T4 lysozyme-hCLDN-4. Superposition of the 
claudins from these structures show cCpE moves as a rigid-body with a rocking motion within the 
claudin hand (Figure S8B). These movements influence the conformations of claudin “fingers” and 
in turn alter the sizes and shapes of solvent exposed pockets at the interfaces of these complexes 
(Figure S9). We found that the hCLDN-4/cCpE interface has an area of 2663 Å2 and that a solvent 
accessible pockets exists there and has a volume of 5281 Å3 (Figure 2C). Solvent pockets are 
observed at the interfaces of other claudin/cCpE complexes, making them subtype-specific 
features useful for comparing cCpE interactions with claudins (Figure S10) (1). These structural 
overlays illustrate cCpE can adopt numerous conformational ensembles depending on the claudin 
it binds and underscores how the unique structures of the solvent accessible pockets at the protein 
interfaces act as subtype-specific features of claudin/cCpE complexes. 
Previously, a crystal structure of a C-terminally truncated form of hCLDN-4 fused on the N-
terminus to T4 lysozyme (T4L-hCLDN-4) and bound to cCpE was determined to 3.5 Å (4). This 
complex had a 1:1 hCLDN-4/cCpE stoichiometry but packed in an antiparallel tetrameric 
arrangement (Figure S5). Comparing T4L-hCLDN-4 and our hCLDN-4, the cCpEs have an RMSD 
of 0.84 Å between Cα atoms while the Cα RMSD between the CLDN-4s is 1.4 Å, indicating 
significant differences. Superposition of hCLDN-4 between structures shows conformational 
deviations are present in the ECS, especially in the loops encompassing ECL1-4 (Figure S11A). 
The crystal packing of T4L-hCLDN-4 reveals ECL3 of chain A interacts with antiparallel oriented 
claudins from chain C and E; and cCpE makes crystallographic and non-crystallographic symmetry 
contacts on four sides with T4L (chain C, E, and G) and another cCpE from chain H. It is likely 
these contacts limit cCpE’s conformational sampling, influence its orientation, and the resulting 
movements of the two ECS of hCLDN-4. This would explain the 0.84 Å Cα deviations we observe 
between structures and why the intermolecular interactions differ. T4L-hCLDN-4 ECS2 makes 





with cCpE. For the T4L-hCLDN-4/cCpE complex six residues in ECS1 and five residues in ECS2 
contribute most to binding cCpE, which corresponds to 24% of all ECS2 residues and 12% in ECS1; 
much less than in our hCLDN-4/cCpE complex. Furthermore, structural comparison reveals the 
hydrogen bonding network of the cCpE-binding motif from hCLDN-4/cCpE (Figure 3A) is less 
extensive in T4L-hCLDN-4/cCpE (Figure S11B). In T4L-hCLDN-4/cCpE the ECL3 moves to 
contact neighboring antiparallel claudins; altering TM2, opening the solvent exposed pocket, and 
creating conformational differences in the bonding network side chains. These changes result in 
losses to cCpE interactions for Arg158 and Leu531. Arg158 makes no interactions with cCpE 
residues and Leu531 forms only five non-polar and one polar interaction versus eight non-polar 
and three potential polar interactions for Leu531 in our hCLDN-4/cCpE complex (Figure S6A). The 
other major difference between these two complexes is that Gln156 and the conformation of ECL4 
is significantly altered by cCpE Asp225 in the T4L-hCLDN-4/cCpE complex. This causes cCpE 
Asp225 to be unable to ionically interact with Arg158, and Gln156 unable to form polar interactions 
with cCpE Arg227 or Ser313. In summary, the antiparallel crystal packing as well as the presence 
of T4L in the T4L-hCLDN-4/cCpE complex significantly hinders the conformational freedom of both 
hCLDN-4 and cCpE, trapping them in a state less conducive to tight association. The structure of 
the hCLDN-4/cCpE complex reported here reveals more numerous and unique intermolecular 
interactions that form at a multitude of structural elements, which we hypothesize to be a more 
accurate representation of in vitro and in vivo complexes. 
The recently reported 3.6 Å crystal structure of a mCLDN-3/cCpE complex gives a glimpse into 
the associations between toxin and another high-affinity gut-expressing claudin (Table 1) (2). The 
cCpE and claudin conformations amid mCLDN-3 and our hCLDN-4 have RMSDs between Cα 
atoms of 0.62 Å and 1.8 Å, respectively. Differences in claudin conformations primarily arise in the 
loops encompassing ECL1-4. The cCpE binding pose alters the conformations of ECL1-4 in 
mCLDN-3 so that cCpE moves out of the claudin “palm” completely and pushes toward the tips of 
the fingers compared to hCLDN-4 (Figure S11C). The mCLDN-3 NPLVP152 motif accesses the 
pocket between β4 and β8–β9 of cCpE but does not penetrate it as deeply as the NPLVA153 motif 
of hCLDN-4 (Figure S11D). Two prolines in the mCLDN-3 NPLVP152 motif limit the flexibility of 
ECL4 prohibiting it from adapting to the cCpE surface groove when positioned like cCpE in hCLDN-
4. These prolines align mCLDN-3 Leu150 with hCLDN-4 Pro150 instead of Leu151, preventing 
Leu150 from entering the cCpE groove. As hCLDN-3 has a NPVVP152 motif we speculate that the 
lower binding affinity for cCpE that we measured for it is a result of Val150 not being able to 
penetrate the cCpE surface groove as extensively as Leu150 of mCLDN-3 or Leu151 of hCLDN-4 
(Table 1). In addition, the cCpE-binding motif hydrogen bonding network is severely disrupted due 
to a lack of cCpE contacts, the arginine stacking is lost and Arg227 of cCpE makes no ionic contacts 
to any mCLDN-3 side chain. The resulting cCpE pose decreases the claudin/cCpE interface area 
and creates a solvent accessible pocket at least twice as large in mCLDN-3 compared to hCLDN-
4 (Figures S10D and S10H). This cCpE pose may be influenced by contacts with an antiparallel 
neighboring mCLDN-3/cCpE complex, where the ECS interact with TM1 and TM2 (Figure S5C). 
In structures of hCLDN-9 in complex with cCpE previously determined by our lab we observed two 
cCpE orientations with one having a larger solvent exposed pocket than the other—highlighting 
that multiple cCpE poses may exist when bound to claudins although they are difficult to trap 
individually using crystallography (1). Because hCLDN-4 and mCLDN-3 share 75% residue identity 
in the cCpE-binding motif we hypothesize that mCLDN-3 can form nearly identical interactions with 
cCpE, with subtle changes caused by the NPLVP152 motif, but that these interactions were not 
observed due to the steric influence of antiparallel molecules as well as the cCpE interactions with 
symmetry-related molecules in the crystal packing. The hypothesis that mCLDN-3 and hCLDN-4 
can bind cCpE nearly identically will require validation via new structures where complexes do not 
pack in antiparallel orientations.  
Prediction of NPLVA153 Structure and Leu151Val Mutant Function in hCLDN-4. Structural 
comparisons of the mCLDN-3/cCpE and hCLDN-4/cCpE complexes reveal structural information 
about ECL4’s NPLVA153 motif that are useful for interpreting our studies. We demonstrate the 
biophysical function of Leu151 in enterotoxin binding but have not postulated how the more hCLDN-





wild type hCLDN-4 (Table 1) or how this mutant maintains longer complexes with cCpE compared 
to hCLDN-3 (Figure 5B). Sequence alignments show 70% identity between hCLDN-3 and -4 
overall and 67% identity in the cCpE-binding motif (Figures 6 and S3). In ECS2, hCLDN-3 and -4 
share only 63% identity. The two mutations in hCLDN-4L151V/A153P improves this identity to hCLDN-
3 11%, to 74%, but there remains 26% divergence. This contrasts to comparisons to wild type 
hCLDN-4, where ECS identity between hCLDN-4L151V/A153P remains high at 89%. The increased 
sequence identity of hCLDN-4L151V/A153P to hCLDN-4 (89%) over hCLDN-3 (74%) explains why 
hCLDN-4L151V/A153P binds cCpE more like hCLDN-4 (Table 1). The structural basis of this is hard to 
surmise without structures of hCLDN-3 or hCLDN-4L151V/A153P in complex with cCpE. But, we 
hypothesize that the structure and conformation of ECS2, which is important for cCpE binding, 
differs between hCLDN-3 and -4 due to the 37% sequence divergence in ECS2 residues between 
subtypes. Indeed, comparison of hCLDN-4 and mCLDN-3 in complex with cCpE reveals the 
presence of structural perturbations in ECS2 that result in alternate binding modes of cCpE 
(Figures S11C and S11D). The structural orientation of the position three residues, Leu150/151, 
are misaligned in the one amino acid shorter mCLDN-3 compared to hCLDN-4. As hCLDN-3 is 
also one amino acid shorter and has a Val150 rather than Leu150 of mCLDN-3, these two changes 
would disallow the position three side chain of hCLDN-3 from aligning to and penetrating the cCpE 
surface groove deeply. Therefore, the higher structural homology between hCLDN-4L151V/A153P and 
hCLDN-4 would mean that the NPVVP153 motif of the former would align and potentially somewhat 
penetrate the cCpE surface groove (Figure S11D). We believe that this would explain why hCLDN-
4L151V/A153P has only 5-fold lower affinity and 4-fold lower t1/2 compared to hCLDN-4 (Table 1), and 
why its complex with cCpE is maintained outside of cells like other high-affinity binding claudins 
(Figure 5B). The loss of Leu151 decreases the binding affinity to cCpE, but residues outside of the 
NPVVP153 motif in the mutant hCLDN-4L151V/A153P can compensate for this loss better compared to 
hCLDN-3. This exercise shows how residues outside of the NPLVA153 and cCpE-binding motifs 
facilitate toxin binding by structural alteration of ECS2, that the structures of ECS2 likely differ 
between hCLDN-3 and -4, and further verifies that no residue solely directs claudin/cCpE complex 
formation. 
SI Methods 
hCLDN-4 and Enterotoxin Expression, Purification, and Complex Formation. Homo sapiens 
claudin-4 gene was subcloned into the pFastBac1 (ThermoFisher) vector and expressed in Tn5 
(Trichoplusia ni, High Five, Expression Systems) cells with a C-terminal decahistidine tag preceded 
by a thrombin cleavage site (hCLDN-4-His10). Tn5 cells in suspension were infected with 
baculovirus particles generated according to the manufacturer’s protocol at a MOI of 0.2 and 
cultured for 48 hours at 27°C. Cells were harvested by centrifugation and the pellet resuspended 
in Lysis buffer containing 50 mM Tris pH 7.4, 200 mM NaCl, 1 mM PMSF, and EDTA-free 
SigmaFast protease tablets (Sigma). Cells were sonicated at 4°C, and the crude lysate was 
resuspended in Lysis buffer supplemented with 1 M NaCl, dounce homogenized, and membranes 
prepared via ultracentrifugation at 100,000 xg for 1 hour. Membrane pellet was resuspended in 
Lysis buffer, dounce homogenized, and solubilized with 1% (w/v) n-undecyl-β-D-maltopyranoside 
(UDM, Anatrace) and 0.04% cholesteryl hemisuccinate (CHS, Anatrace) overnight at 4°C. Insoluble 
material was removed by ultracentrifugation at 100,000 xg for 30 minutes, and the supernatant 
spiked with 15 mM imidazole, filtered through a 1.2 μm filter, then incubated with NiNTA resin 
(Sigma) for 12 hours at 4°C. Resin was captured and washed with Lysis buffer containing 500 mM 
NaCl, 25 mM imidazole, and 0.29% UDM, followed by a wash with Lysis buffer containing 300 mM 
NaCl, 50 mM imidazole, and 0.29% UDM. Lysis buffer containing 150 mM NaCl and 0.15% UDM 
was then used for incubation and protein release by thrombin, which occurred overnight at 4°C. 
Sample was captured and used for binding studies and cCpE complex formation. 
 Clostridium perfringens enterotoxin (CpE-His10) and its C-terminal domain comprising residues 
194-319 (cCpE-His10) were subcloned into the pFastBac1 vector and expressed in Tn5 cells with 
a C-terminal decahistidine tag preceded by a thrombin cleavage site. Tn5 cells in suspension were 
infected with baculovirus particles at a MOI of 4.0 and cultured for 72 hours at 27°C. Cells were 
harvested by centrifugation and the pellet resuspended in Lysis buffer, as above. Cells were 





NaCl, dounce homogenized, and cell debris removed via ultracentrifugation at 100,000 xg for 1 
hour. The supernatant was spiked with 15 mM imidazole, filtered through a 1.2 μm filter, then 
incubated with NiNTA resin for 12 hours at 4°C. Protein purification of CpE and cCpE was similar 
to hCLDN-3 apart from the omission of UDM and CHS in the buffers. Both toxins were captured, 
concentrated, 0.2 μm filtered, then loaded onto a Superdex 200 Increase 10/300 GL (GE 
Healthcare Life Sciences) equilibrated in  SEC buffer (10 mM Hepes pH 7.4, 100 mM NaCl, and 
4% glycerol). Peak fractions from size-exclusion chromatography (SEC) were collected, 
concentrated, then flash-frozen in liquid nitrogen and stored at -80°C until needed for complex 
formation, and binding and cytotoxicity assays. 
 Purified hCLDN-4 was mixed with cCpE at a ratio of 1:1.5 (moles:moles) and nutated overnight 
at 4°C. The protein complex was concentrated, filtered through a 0.2 μm filter and loaded onto a 
Superdex 200 Increase column equilibrated in SEC buffer with 0.1% UDM. Peak fractions from 
SEC were collected, concentrated to 15 mg/mL, and used for crystallization. 
Crystallization and Structure Determination. Crystals were grown at 4°C using vapor diffusion 
by mixing 1 μL of complex with 1 μL of a mother liquor containing 100 mM DL-malic acid, 2-(N-
morpholino)ethanesulfonic acid, and Tris base (1:2:2) pH 6.0 and 25% polyethylene glycol 1500. 
Rod-shaped crystals appeared at 12 hours and grew to variable lengths approaching 500 μm at 
the longest edge. Crystals were cryoprotected by removing excess mother liquor using a brief soak 
in Al’s oil (50:50 paraffin/silicon, Hampton Research), then flash-frozen in liquid nitrogen. Data from 
a single crystal were collected at the Advanced Light Source beamline 8.3.1 at -170°C at a 
wavelength of 1.11583 Å, and processed using XDS (14) in space group P212121. The structure 
was solved by molecular replacement (MR) in PHENIX (15) Phaser-MR (16) using an all poly-
alanine version of hCLDN-9 and the cCpE from PDB ID 6ov2 (1), searching sequentially for 
hCLDN-9 then cCpE using two search components. To unbias the orientation of cCpE, it was 
manually moved away from poly-alanine hCLDN-9 5000 Å using Coot (17). One solution was found 
in space group P212121 using a search for all possible solutions in the same point group, and high-
quality maps were obtained post-MR. This initial incomplete model was used for subsequent model 
building and refinement in Coot (17) and Phenix (18), culminating in the final placement of residues 
5-186 (87%) of hCLDN-4 and 191-319 (100%) of cCpE into the electron density. Final R factors for 
the hCLDN-4/cCpE complex is Rwork=29.38% and Rfree=29.57%. All structure figures were 
generated using PyMOL (19). Structural biology applications used in this project were compiled 
and configured by SBGrid (20). Data collection and refinement statistics are summarized in Table 
S1. 
Claudin Expression, Mutagenesis, and Purification. The genes for human claudin-1, -3, and -4 
and mouse claudin-3 and -4 were subcloned into pFastBac1 and expressed in Tn5 cells with a C-
terminal decahistidine tag preceded by a thrombin cleavage site (CLDN-His10) or with a C-terminal 
decahistidine tag preceded by eGFP (CLDN-eGFP-His10). The hCLDN-3V150L/P152A mutant was 
created using the forward primer (5’-CTTCTACAACCCCCTGGTGGCCGAGGCGCAGAAGCG-3’) 
and equivalent reverse compliment, while the hCLDN-4L151V/A153P mutant used the forward primer 
(5’- CTTCTACAATCCGGTGGTGCCCTCCGGGCAGAAGCG-3’). Protocols for expression and 
purification of all CLDN-His10 claudins were identical to those of hCLDN-4-His10. Post-IMAC and 
thrombin digested CLDN-His10 samples were captured and used for cCpE and CpE binding studies. 
CLDN-eGFP-His10 were not purified and used for cytotoxicity, microscopy, and post-infection 
binding assays. 
Pocket Detection and Measurements. The PDB coordinates for chain A (CLDN) and B (cCpE) 
for hCLDN-4 in complex with cCpE (7kp4), 6ov2, 6ov3, 6ake, 5b2g, and 3x29 were uploaded to 
Fpocket 1.0 (21) and PDBsum (22). For PDBSum the Interface Area and for Fpocket the “Real 
Volume (approximation)” is reported (Figure S10H). For 6ake Fpocket could not define the pocket 
accurately as it is so solvent exposed the probe likely could not distinguish borders. Comparison of 
pockets found from Fpocket (21) and MetaPocket 2.0 (23) were shown to be nearly identical. 






Affinity and Kinetic Measurements Using Bio-layer Interferometry (BLI). Briefly, cCpE-His10 
and CpE-His10 were expressed in Tn5 cells, the cells were lysed and purified via NiNTA as 
described above. Instead of protease cleavage however the proteins were eluted in 500  mM 
imidazole, buffer exchanged into no imidazole buffer, concentrated to 1 mg/mL, then flash frozen 
in liquid nitrogen and stored at -80°C until use. CLDN-His10  claudins used in these analyses were 
purified as described above; post-cleaved protein of >90% purity was flash frozen in liquid nitrogen 
at 1 mg/mL and stored at -80°C until use. 
BLI analyses were performed using an Octet© RED384 System (FortéBIO) with cCpE-His10 
and CpE-His10 immobilized on NiNTA or Anti-His (HIS2) Biosensors (Dip and Read™) and free 
claudins. Assays were designed and setup using Data Acquisition and analyzed using Data 
Analysis versions 10.0 from Octet© Software. Experiments were run using 200 μL sample volume 
in black 96-well flat bottom microplates (Greiner Bio-One). Each experiment consisted of a sensor 
Wash (60 seconds) followed by toxin Loading (200 seconds), a Baseline measurement (120 
seconds), and then an Association and Dissociation (300 seconds each) steps. Wash, Baseline, 
and Dissociation measurements were performed in SEC buffer with 0.1% UDM, and Baseline and 
Dissociation were performed in the same wells. Loading and Association measurements were 
performed in SEC buffer with 0.1% UDM with 10 μg/mL (100 nM) toxin and a range of 0-2000 nM 
claudins, respectively. A minimum of seven and maximum of eight concentrations were used for 
these experiments. For high-affinity claudins, a concentration range of 0-250 nM claudin was used, 
while for low-affinity binders, 0-2000 nM claudin was required. All experiments were run at 25°C 
using an acquisition rate of 5 Hz averaged by 20, in at least duplicate and quadruplicate for hCLDN-
3 and -4. The effect of NaCl salt (5 and 100 mM) and temperature (25 and 37°C) on binding affinities 
of hCLDN-4 were tested prior to analyses and showed no significant differences. 
For high-affinity binders, ligand sensors were subtracted from reference wells, the Y axis was 
aligned to the baseline for the last 5 seconds of measurement, and an inter-step correction was 
applied aligned to dissociation, then processed using Savitzky-Golay Filtering. No significant non-
specific binding of claudins to naked NiNTA sensors were observed using </=250 nM claudin. For 
hCLDN-1 and -3, some non-specific binding to the NiNTA was observed due to the higher 
concentrations required (likely due to the basic claudin C-terminus), in which case a double 
reference subtraction was applied from reference sensors loaded with no toxin in SEC buffer. For 
hCLDN-1 we used both NiNTA and Anti-His (HIS2) biosensors and observed no interactions 
between hCLDN-1 and Anti-His antibody alone; a double reference subtraction was applied for 
these data. Processed data was analyzed using an association and dissociation step, using a 1:1 
model with a global (full) fit applied. and the Rmax was unlinked by sensor using a window of interest 
from 0-300 seconds. All curves were fit using this criteria. In instances where low concentrations 
resulted in negative responses, these wells were excluded from analysis and curve fitting. Data 
related to these experiments are shown in Table 1 and Figure S12. 
Insect Cell Cytotoxicity Assay and Microscopy. Recombinant baculoviruses containing CLDN-
eGFP-His10 and hCLDN-3V150L/P152A-His10 were produced using established methods. To each well 
of a 24-well cell culture plate, 500 μL of 0.6x106 adherent Sf9 (Spodoptera frugiperda, Expression 
Systems) cells were added. After 1 hour at 27°C, virus containing claudins and a non-claudin 
plasma membrane-expressed protein (PMP) were added at a MOI of 1.0. Cultures were rocked 
gently then placed at 27°C. After 36 hours, 75 μg purified cCpE (10 μM) and 25 μg CpE (1.4 μM) 
in SEC buffer were added to the culture medium of two individual wells expressing claudins, PMP, 
and untreated Sf9 cells and placed back at 27°C. Twelve hours post-incubation with enterotoxins, 
Sf9 morphological damage was visualized using an EVOS FL Auto (ThermoFisher) microscope 
with 20x objective. Post microscope visualization, CpE cytotoxicity was quantified using a cell 
viability analysis by gently removing 50 μL of untreated and treated Sf9 cells then adding an 
equivalent volume of 0.04% trypan blue. After 5 minutes, 10 μL of stained cells were transferred to 
a hemacytometer and counted manually in duplicate by two individuals. Viability counts consisted 
of dividing the total number of live cells (unstained) by the total number of cells. Average cell viability 
for toxin treated cells were compared to three controls; 1) Sf9 cells with no baculovirus added in 3 





CpE; 2) Sf9 cells expressing PMP in 3 wells, 1 well that was not treated with any toxin and 2 wells 
that were each treated with cCpE or CpE; and 3) Sf9 cells expressing claudins in 3 wells, 1 of which 
was not treated with any toxin. 
Post-Infection Binding Assay of Claudin/cCpE Complex. Claudin-expressing cells not treated 
with any toxin and cells treated with cCpE from the Cytotoxicity Assay were used for this analysis. 
450 μL of Sf9 cells expressing CLDN-eGFP-His10 were harvested from a 24-well plate by gently 
pipetting and placed in a 1.5 mL microfuge tube (Beckman Coulter). Cells were pelleted at 13,000 
rpm on a table top centrifuge for 2 minutes, culture media was removed and then the pellet was 
resuspended in 1 mL Lysis buffer with 1% (w/v) UDM. The solution was rotated for 1 hour at 4°C. 
After time, samples were spun via ultracentrifugation at 100,000 xg for 20 minutes using a TLA-45 
rotor (Beckman Coulter) to remove insoluble debris. 300 μL of supernatant was loaded onto a 
Superdex 200 Increase column equilibrated in buffer consisting of 25 mM Tris pH 7.4, 150 mM 
NaCl, 0.1% UDM and 1% glycerol. Fluorescence of eGFP (λex=488 nm and λem=509 nm) was 
monitored and the samples were subjected to fluorescence-detection SEC (FSEC) (24). Sf9 cells 
used in the assay had been infected with baculovirus for 48 hours and treated with 10 μM cCpE for 
12 hours before harvesting. Total assay time from harvest to end of FSEC was 2 hours. Control 
samples representing CLDN-eGFP-His10 not treated with toxin from Cytotoxicity Assay were 
incubated with 10 μg cCpE (2 μM), incubated at 20°C for 2 hours, then assayed via FSEC to verify 















Figure S1. Sequence alignment of classic human claudins. Sequences were aligned with T-Coffee 
(25). Highlighted in the sequences with a cylinder helix are TM1-4 (teal), the consensus SLLALP74 
for ECH1 and ECH2 (blue); and noted with arrows are the claudin-defining sequence W30-GLW51-







Figure S2. Claudin structural topology and a model for hCLDN-4 cis homodimers. (A) 
Superposition of hCLDN-4 (teal), hCLDN-9 (blue, 6ov2), mCLDN-3 (purple, 6ake), T4L-hCLDN-4 
(green, 5b2g), mCLDN-19 (orange, 3x29), and mCLDN-15 (brown, 4p79), viewed parallel to the 
membrane (left), rotated 180° (middle), then rotated 90° viewing top-down (right). cCpE is removed 
for clarity. (B) hCLDN-4 monomers were manually docked based on the Zhao et al. (26) model for 
mCLDN-15 cis homodimers. Side chains thought to be involved in cis assembly are labeled and 
colored accordingly, and ECH2 are highlighted with rectangles (teal). Note the loss of hydrogen 
bonds between Ser69/Arg81/Gln78 and Glu159, and the distances between protomers create a 
loss of hydrophobic interactions between Leu73 and Phe147/Tyr148 as compared to structures of 







Figure S3. Sequence alignment of gut claudins. Gastrointestinal-expressing claudins from mouse 
and humans were aligned with T-Coffee (25). Highlighted in the sequences are the NPLVP152 motif 






Table S1. Data collection and refinement statistics. 
 
 hCLDN-4/cCpE 
Data collection  
Beamline ALS 8.3.1 
Space group P 21 21 21 
Cell dimensions  
a, b, c (Å) 70.36, 116.23, 118.05 
⍺, 𝛽, 𝛾 (°) 90, 90, 90 
Asymmetric unit volume (Å3) 241,187 
Asymmetric unit solvent (%) 81.37 
Wavelength (Å) 1.11583 
Resolution (Å)a 59.03-3.37 (3.45-3.37) 
Rmeas (%) 6.30 (594.00) 
Total reflections 75314 (4503) 
Unique reflections 26037 (1756) 
I/σI 8.11 (0.29) 
CC1/2 100.00 (13.90b) 
Completeness (%) 98.00 (88.80) 
Multiplicity 2.90 (2.56) 
Wilson B-factor 156.91 
  
Refinement  
Resolution (Å) 44.81‒3.37 
Number of reflectionsc 24373 (1908) 
Rwork/Rfree 0.2938/0.2957 




Avg. B-factor 170.92 
R.M.S. deviations  
Bond length (Å) 0.003 
Bond angles (°) 0.820 
Molprobity statisticsd  




Poor rotamers (%) 0.00 
C𝛽 deviations (%) 0.00 
Clashscore 12.40 
Molprobity score 1.89 
PDB IDe 7KP4 
 
aValues in parenthesis are for highest resolution shell. 
bPercentage of correlation between intensities from random half-datasets. Correlation significant 
at the 0.1% level (CC1/2*), as calculated by XDS. 
cValues in parenthesis are number of reflections used for Rfree. 
dAs determined by http://molprobity.biochem.duke.edu/ 







Figure S4. The ECL3 and ECH1 from claudin crystal structures. (A) hCLDN-4 structure (teal) and 
2Fo-Fc electron density map (teal, volume) contoured to 1.0σ showing the bulbous density 
surrounding the ECH1 helical remnant. cCpE is removed for clarity. (B) hCLDN-4 structure and 
electron density map as in A (teal) with superposition of hCLDN-9 (blue) and mCLDN-15 (brown) 
structures. Note the conformational differences in ECL3 and the structural differences in ECH1 
between the cCpE-bound hCLDN-4 and -9 complexes and the unbound mCLDN-15. (C) Sequence 
alignments of classic claudins from humans (Figure S1) reveals a consensus sequence for ECH1 






















Figure S5. Crystal packing of claudin/cCpE complexes. Monomer A from claudin/cCpE structures 
were superimposed on hCLDN-4. (A) hCLDN-4 (teal) in complex with cCpE . (B) hCLDN-9 (blue) 
in complex with cCpE (copper). (C) Antiparallel dimeric mCLDN-3 (purple) in complex with cCpE 
(light purple). (D) Antiparallel tetrameric T4L-hCLDN-4 (T4L forest, hCLDN-4 green) in complex 
with cCpE (yellow). (E) Antiparallel dimeric mCLDN-19 (orange) in complex with cCpE (light green). 











Figure S6. Intermolecular interactions in the hCLDN-4/cCpE complex. (A) Bonds between the 
ECS2 of hCLDN-4 (teal, cartoon) and cCpE (gold, cartoon). Potential polar (red, dash), non-polar 
(grey, dash), and arginine stacking (black, dash) interactions between side chains. Side chains are 
represented as sticks with carbon (teal/gold), oxygen (red), and nitrogen (blue) colored, 
respectively. (B and C) Bonds between the ECS1 of hCLDN-4 and cCpE. Proteins, side chains, 
















Figure S7. Amino acid determinants of hCLDN-4 interactions with cCpE. (A) Cartoon 
representation depicting the 9 residues of ECS1 (top) and 8 residues of ECS2 (bottom) that contact 
cCpE through ionic, polar, or non-polar interactions. Residue side chains are shown as sticks with 
surrounding van der Waals surfaces (dots) with carbon (teal), oxygen (red), and nitrogen (blue) 
coloring, respectively. The membrane surface (grey, spheres) calculated by the PPM server (28) 
is shown and cCpE is removed for clarity. (B) All 17 cCpE-binding residues of hCLDN-4 represented 



















Figure S8. Structures of cCpE alone and from complexes with claudins. (A) Superposition of cCpE 
from hCLDN-4 (gold, 7kp4), hCLDN-9 (blue, 6ov2), mCLDN-3 (purple, 6ake), T4L-hCLDN-4 (green, 
5b2g), mCLDN-19 (orange, 3x29), unbound (red, 2quo), and full-length CpE (black, 3am2). Chain 
B of cCpE from cCpE-bound structures was used for superpositions and claudins are removed for 
clarity. The N-terminal domain of CpE is shown for reference. (B) Superposition of claudins bound 
to cCpE. cCpE are colored as in A with hCLDN-4 (teal, cartoon) and membrane (grey, spheres) 
shown for reference. Chain A of claudins from cCpE-bound structures was used for superpositions. 







Figure S9. Solvent exposed pockets at claudin/cCpE interfaces. (A) hCLDN-4/cCpE (teal/gold, 
7kp4). (B) hCLDN-9 closed/cCpE (blue/sand, 6ov2). (C) hCLDN-9 open/cCpE (red/grey, 6ov3). (D) 
mCLDN-3/cCpE (purple/light purple, 6ake). (E) T4L-hCLDN-4/cCpE (dark green and green/yellow, 
5b2g). (F) mCLDN-19/cCpE (orange/light green, 3x29). Claudin/cCpE complexes (cartoons) are 
shown with pocket volumes (dark grey, spheres). Pockets were calculated with MetaPocket 2.0 









Figure S10. Comparison of interface pockets in claudin/cCpE complexes. Proteins were removed 
and the solvent accessible pockets from Figure S9: (A) hCLDN-4/cCpE (teal), (B) hCLDN-9 
closed/cCpE (blue), (C) hCLDN-9 open/cCpE (red), (D) mCLDN-3/cCpE (purple), (E) T4L-hCLDN-
4/cCpE (green), and (F) mCLDN-19/cCpE (orange) are shown as spheres. (G) Pockets from A-F 
were superposed and viewed parallel to the membrane (middle), rotated +90° (right, view down to 
membrane surface) and -90° (left, view up through membrane) to demonstrate their unique shapes. 
(H) The areas of the claudin/cCpE interfaces and the pocket volumes as calculated by PDBSum 
and Fpocket (21, 22) are shown relative to hCLDN-4. Note that hCLDN-4 has the highest interface 
area and smallest pocket volume. *The low interface area of mCLDN-3 in complex with cCpE 
produces a pocket so large that the borders are difficult to define with a probe and thus are not 





Figure S11. Structural alterations between high-affinity cCpE claudin receptors. (A) Superposition 
of hCLDN-4/cCpE (teal/gold) and T4L-hCLDN-4/cCpE (green/yellow). (B) Side chain alterations in 
the cCpE-binding motif between hCLDN-4/cCpE and T4L-hCLDN-4/cCpE. Complexes and side 
chains are represented and colored as in A. (C) Superposition of hCLDN-4/cCpE (teal/gold) and 
mCLDN-3/cCpE (purple/light purple). (D) ECL4 conformations between hCLDN-4 (teal) and 
mCLDN-3 (purple) with cCpE (gold, surface) from hCLDN-4 (top); and with cCpE (light purple, 
surface) from mCLDN-3 (bottom). Complexes are colored as in C. Note the altered ECL4 structure 







Figure S12. Measurements of claudin binding to enterotoxins. Sensograms from BLI using 
immobilized cCpE and CpE in SEC buffer with UDM detergent binding to: (A) hCLDN-3, (B) hCLDN-
4, (C) mCLDN-3, (D) hCLDN-3V150L/P152A, (E) hCLDN-4L151V/A153P, and (F) hCLDN-1. Raw data 
(various colors) are overlaid with best fit lines (red). The vertical red line at 300 seconds indicates 
start of dissociation recording. Note rapid dissociation of hCLDN-1 and -3 from enterotoxin-bound 
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